Announce Date | 02/18/2025 |
EPS Normalized Actual | $0.48 (Miss by $-0.3) |
EPS GAAP Actual | $0.48 (Miss by $-0.3) |
Revenue Actual | $4.26B |
Revenue Surprise | Beat by $4260M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.61302 |
EPS GAAP Estimate | $0.61302 |
Revenue Estimate | $4.327549B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 3.82 | 9.34 | 3.56424 | 3.98125 | 1 |
Dec 2026 | 3.44135 | 10.37 | 3.27 | 3.55404 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 10.83 | 10.83 | 4.26B | 10.33% | 4260M |
FQ3 2024 (Sep 2024) | 0 | 0 | 4.094B | 3.2% | 4094M |
FQ2 2024 (Jun 2024) | 0 | 0 | 4.227B | 6.81% | 4227M |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 3.734B | -0.48% | 3734M |
FQ4 2023 (Dec 2023) | 0 | 0 | 3.82B | 2.88% | 3820M |
FQ3 2023 (Sep 2023) | 0 | 0 | 3.963B | 8.86% | 3963M |
FQ2 2023 (Jun 2023) | 0.36 | 0.36 | 3.939B | 16.25% | 3939M |
FQ1 2023 (Mar 2023) | -0.92 | -0.92 | 3.752B | 100% | 3752M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
0.61302
Consensus Revenue Estimates
4.327549B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.89204 | -- | 0.85931 | 0.92063 | 1 |
FQ2 2027 (Jun 2027) | 0.87757 | -- | 0.84537 | 0.9057 | 1 |
FQ1 2027 (Mar 2027) | 0.74697 | -- | 0.71956 | 0.77091 | 1 |
FQ4 2026 (Oct 2026) | 1.01561 | -- | 0.99024 | 1.05888 | 0 |
FQ3 2026 (Jul 2026) | 0.94337 | -- | 0.9198 | 0.98357 | 0 |
FQ2 2026 (Jun 2026) | 0.94337 | -- | 0.8752 | 1.0572 | 3 |
FQ1 2026 (Mar 2026) | 0.70194 | -- | 0.65122 | 0.78664 | 3 |
FQ4 2025 (Oct 2025) | 0.89115 | -1115.28 | 0.86888 | 0.92912 | 0 |
FQ3 2025 (Jul 2025) | 0.81069 | -- | 0.79044 | 0.84523 | 0 |
FQ2 2025 (Jun 2025) | 0.77569 | -- | 0.71964 | 0.86929 | 3 |
FQ1 2025 (Mar 2025) | 0.61302 | 42.91 | 0.56872 | 0.68699 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 5.14B | -- | 5B | 5.27B | 2 |
FQ2 2027 (Jun 2027) | 5.18B | -- | 5.03B | 5.31B | 2 |
FQ1 2027 (Mar 2027) | 4.51B | -- | 4.39B | 4.63B | 2 |
FQ4 2026 (Oct 2026) | 4.91B | -- | 4.82B | 5.07B | 0 |
FQ3 2026 (Jul 2026) | 4.81B | -- | 4.72B | 4.97B | 0 |
FQ2 2026 (Jun 2026) | 4.81B | -- | 4.54B | 5.25B | 4 |
FQ1 2026 (Mar 2026) | 4.35B | -- | 4.11B | 4.75B | 4 |
FQ4 2025 (Oct 2025) | 4.8B | 11.2 | 4.7B | 4.95B | 0 |
FQ3 2025 (Jul 2025) | 4.57B | 10.34 | 4.48B | 4.72B | 0 |
FQ2 2025 (Jun 2025) | 4.52B | 6.42 | 4.27B | 4.94B | 2 |
FQ1 2025 (Mar 2025) | 4.33B | 13.72 | 4.09B | 4.73B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
1
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 10.83 | 10.83 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 0.36 | 0.36 | 100% | |
FQ1 2023 (Mar 2023) | -0.92 | -0.92 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $4.26B | $4260M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.09B | $4094M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.23B | $4227M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.73B | $3734M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.82B | $3820M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.96B | $3963M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.94B | $3939M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.75B | $3752M | 100% |